Innovator IBD 50 ETF (NYSEARCA:FFTY) Stock Falls 4.2% – Should You Sell?

Innovator IBD 50 ETF (NYSEARCA:FFTY) fell 4.2% on Monday. The stock traded as low as $31.15 and last traded at $31.15. 57,254 shares changed hands during mid-day trading, an increase of 14% from the average daily volume of 50,187 shares. The stock had previously closed at $32.50.

Innovator IBD 50 ETF Stock Performance

The firm has a market cap of $54.51 million, a PE ratio of 30.34 and a beta of 1.48. The stock has a fifty day moving average price of $34.82 and a 200-day moving average price of $37.48.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of FFTY. Guardian Wealth Advisors LLC NC purchased a new stake in Innovator IBD 50 ETF during the 2nd quarter worth $507,000. Kraematon Investment Advisors Inc. purchased a new position in Innovator IBD 50 ETF in the second quarter valued at about $1,021,000. Concurrent Investment Advisors LLC raised its position in Innovator IBD 50 ETF by 11.1% in the second quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after purchasing an additional 6,321 shares during the period. KFG Wealth Management LLC acquired a new position in shares of Innovator IBD 50 ETF during the second quarter worth about $201,000. Finally, WorthPointe LLC lifted its stake in shares of Innovator IBD 50 ETF by 18.3% during the second quarter. WorthPointe LLC now owns 24,412 shares of the company’s stock worth $1,295,000 after purchasing an additional 3,771 shares in the last quarter.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.